
CAS 269718-83-4
:Pardoprunox hydrochloride
Description:
Pardoprunox hydrochloride is a chemical compound that acts as a dopamine receptor agonist, primarily targeting the D2 and D3 subtypes. It is classified as a potential treatment for various neurological disorders, including Parkinson's disease and schizophrenia, due to its ability to modulate dopaminergic activity in the brain. The compound is typically presented as a hydrochloride salt, which enhances its solubility and stability in aqueous solutions. Pardoprunox has been studied for its pharmacological properties, including its effects on motor function and cognitive performance. Its mechanism of action involves stimulating dopamine receptors, which can help alleviate symptoms associated with dopamine deficiency. Additionally, the compound may exhibit a favorable side effect profile compared to traditional dopaminergic therapies, making it a subject of interest in clinical research. As with any pharmacological agent, understanding its pharmacokinetics, potential interactions, and safety profile is crucial for its therapeutic application.
Formula:C12H15N3O2·ClH
InChI:InChI=1S/C12H15N3O2.ClH/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9;/h2-4H,5-8H2,1H3,(H,13,16);1H
InChI key:InChIKey=NQRIKTDKFHAOKC-UHFFFAOYSA-N
SMILES:O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3.Cl
Synonyms:- 2(3H)-Benzoxazolone, 7-(4-methyl-1-piperazinyl)-, hydrochloride (1:1)
- 2(3H)-Benzoxazolone, 7-(4-methyl-1-piperazinyl)-, monohydrochloride
- DU 126891 hydrochloride
- Pardoprunox hydrochloride
- SLV 308 hydrochloride
- Slv-308
- Sme-308
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Pardoprunox hydrochloride
CAS:<p>Pardoprunox hydrochloride (SLV-308 hydrochloride) is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1)</p>Formula:C12H16ClN3O2Purity:98.95% - 99.13%Color and Shape:SolidMolecular weight:269.73Pardoprunox Hydrochloride
CAS:Controlled Product<p>Applications Pardoprunox Hydrochloride is an antiparkinsonian drug currently under development by Solvay for the treatment of Parkinson's disease.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Glennon, Jeffrey C., et al.: Synapse, 60, 599 (2006); Wolf, William A., et al.: Current Opinion in Investigational Drugs, 4, 878 (2003); Tayarani-Binazir, K., et al.: Exp. Neurol.: 226, 320 (2010)<br></p>Formula:C12H15N3O2·ClHColor and Shape:NeatMolecular weight:269.727



